Yes, Medicare covers Orencia (abatacept), but whether Part B or Part D pays depends on how you take it. The IV infusion given at a clinic is covered under Part B as a medical service. The prefilled syringe you inject at home is covered under Part D as a prescription drug. That split determines your deductible, your coinsurance, and whether your yearly out-of-pocket spending has a ceiling.
Why the Form of Orencia Changes Everything
Orencia comes two ways. The intravenous infusion is mixed and administered by a healthcare professional in a doctor’s office, infusion center, or hospital outpatient department. Because a medical professional delivers it, Medicare treats it as a Part B medical service.
The subcutaneous version is a prefilled syringe dispensed by a pharmacy for you to inject at home. Because you administer it yourself, Medicare treats it as a Part D prescription drug. Part B and Part D have different deductibles, different cost-sharing, and, most importantly, different rules about how much you can spend in a year.
What Part B Pays for the IV Infusion
When you get Orencia as an infusion in an outpatient setting, Part B covers the drug and the infusion service. Two things have to be true: your doctor has to determine the treatment is medically necessary, and the provider has to accept Medicare assignment.1Medicare. What Part B covers
After you meet the annual Part B deductible of $283 in 2026, you pay 20% coinsurance on the Medicare-approved amount for each infusion.2Medicare. Costs If the infusion happens in a hospital outpatient department instead of a freestanding clinic, the hospital may charge an additional facility fee.3Medicare. Prescription drugs (outpatient)
Here is the catch with Original Medicare Part B: there is no annual out-of-pocket maximum. Your 20% coinsurance keeps accumulating all year. A single infusion at the Medicare-approved rate can run into the thousands of dollars, putting your share in the range of several hundred dollars per visit, repeated every four weeks after the loading doses. Without supplemental coverage, annual out-of-pocket costs for Part B infusions can significantly exceed what you would pay for the self-injected form under Part D.
What Part D Pays for the Self-Injected Syringe
The subcutaneous form is covered under a stand-alone Part D plan or a Medicare Advantage plan that includes drug coverage. Coverage depends on whether your specific plan lists Orencia on its formulary. Most plans that cover it place Orencia on a specialty tier (Tier 4 or Tier 5), which carries the highest cost-sharing.
Starting in 2025, the Inflation Reduction Act simplified Part D into three phases and eliminated the old coverage gap. For 2026, the structure works like this:4Medicare. How much does Medicare drug coverage cost?
- Deductible phase: you pay 100% of your drug costs until you meet the deductible. No plan can set a deductible higher than $615 in 2026, and some plans have none.
- Initial coverage phase: you pay 25% coinsurance on covered drugs until your out-of-pocket spending reaches $2,100.
- Catastrophic phase: once you hit the $2,100 cap, you pay nothing for covered Part D drugs for the rest of the calendar year.
For an expensive biologic like Orencia, you will likely reach the $2,100 cap early in the year, especially if you fill your first prescription in January. Your total Part D spending on Orencia is effectively capped at $2,100 for 2026, regardless of the drug’s list price.5Medicare. Before using this payment option
The list price for the self-injected form is roughly $6,071 for a 28-day supply as of January 2026. Most Medicare beneficiaries pay far less. According to the manufacturer, over 85% of Medicare patients pay $25 or less per month for the self-injected form, largely because the $2,100 cap and manufacturer discounts that count toward it keep spending predictable.
Conditions Medicare Will Cover Orencia For
Medicare covers Orencia for its three FDA-approved uses: moderate to severe rheumatoid arthritis in adults, active polyarticular juvenile idiopathic arthritis in patients two and older, and active psoriatic arthritis in patients two and older. Coverage under Part B requires the drug not be self-administered, so only the IV infusion qualifies for the medical benefit. The self-injected form is covered under Part D for the same conditions, as long as the drug appears on your plan’s formulary.
Prior Authorization and Step Therapy
Nearly every Medicare plan requires prior authorization before covering Orencia. Your prescribing doctor has to submit documentation showing the drug is medically necessary. Without approval, you risk being billed for the full cost. Turnaround varies by plan, so request authorization well before your first scheduled dose.
Many plans also require step therapy: you have to try one or more lower-cost medications first and show they did not work or caused side effects you could not tolerate. For rheumatoid arthritis, that often means trying a conventional disease-modifying drug like methotrexate before the plan will approve a biologic. If your doctor believes step therapy would be medically harmful in your case, they can request an exception, but the plan is not required to grant it automatically.
How Medicare Advantage Handles Orencia
Medicare Advantage (Part C) plans cover everything Original Medicare covers, including Part B infusion drugs. Cost-sharing usually looks different, though. Many Advantage plans charge a fixed copay per infusion visit rather than 20% coinsurance, and the amount depends on whether the provider is in-network. Advantage plans are also required to have an annual out-of-pocket maximum, which Original Medicare does not have, so your Part B exposure has a ceiling.
Most Advantage plans include Part D coverage, so the self-injected form would fall under the same plan. The $2,100 out-of-pocket cap and three-phase structure still apply. Check your plan’s formulary, tier placement, and prior authorization rules, because they vary.
How to Bring Your Costs Down
Medigap for the Part B Infusion
If you get Orencia as an infusion under Original Medicare, a Medigap policy can cover most or all of your 20% coinsurance. Most standardized Medigap plans cover Part B coinsurance at 100%, which closes off the uncapped exposure that makes Part B biologics so expensive.6Medicare. Compare Medigap Plan Benefits Plans K and L cover coinsurance at 50% and 75% with lower premiums. Monthly premiums vary widely by location, age, and insurer.
Medicare Prescription Payment Plan
Even with the $2,100 cap, paying several hundred dollars at the pharmacy in January can be a shock. The Medicare Prescription Payment Plan, available since 2025, lets you spread Part D out-of-pocket costs into capped monthly installments over the year instead of paying large amounts up front. Every Part D plan has to offer it.7CMS. Medicare Prescription Payment Plan Contact your plan to opt in. Your total annual costs stay the same; only the timing changes.
Extra Help and Medicare Savings Programs
The Extra Help program (also called the Low-Income Subsidy) sharply reduces Part D costs for beneficiaries with limited income and resources. If you qualify, your Part D deductible drops to zero and your copay for each covered drug is a small fixed amount.8Medicare. Fact sheet – Medicare’s Extra Help Program You apply through the Social Security Administration.9Social Security Administration. Apply for Medicare Part D Extra Help program
For Part B costs, Medicare Savings Programs help. The Qualified Medicare Beneficiary (QMB) program pays your Part B premiums, deductibles, and coinsurance, which would cover your share of Orencia infusion costs. The Specified Low-Income Medicare Beneficiary (SLMB) and Qualifying Individual (QI) programs pay Part B premiums only. All three also automatically qualify you for Extra Help.10Medicare. Medicare Savings Programs
Charitable Copay Assistance
Federal anti-kickback rules prohibit drug manufacturers from offering copay cards or coupons directly to Medicare beneficiaries. Independent charitable foundations can legally provide copay assistance to people on Medicare. The PAN Foundation, for example, offers rheumatoid arthritis grants that cover Orencia copays for government-insured patients, with initial grants of $4,700 and up to $9,400 per year. Funds are limited and open or close based on donations, so applying early in the year helps. The PAN Foundation’s FundFinder tool tracks availability across multiple organizations. Your doctor’s office or the specialty pharmacy dispensing Orencia can often identify which programs are currently open.
If Your Plan Denies Coverage
If your Part D plan denies Orencia, you have the right to request a redetermination. You, your prescribing doctor, or an authorized representative can file within 65 calendar days of the denial notice. Standard requests are submitted in writing (unless your plan accepts verbal requests), and the plan has to decide within seven calendar days. If your health would be seriously harmed by waiting, ask for an expedited review, which can be verbal and requires a decision within 72 hours. If the plan upholds the denial, you can escalate to an independent review entity.11CMS. Redetermination by the Part D Plan Sponsor
Part B denials follow a similar escalation path through Medicare’s general appeals system. In either case, a detailed letter of medical necessity from your doctor explaining why alternatives failed or are inappropriate makes the appeal much stronger.